The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination

Những quyển sách tương tự

• Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution
  Bằng: Grottke, Oliver, et al.
  Được phát hành: (2019)
• Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies
  Bằng: Norris, Stephen, et al.
  Được phát hành: (2017)
• Authors’ Reply to Kamel et al.: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”
  Bằng: Glund, Stephan, et al.
  Được phát hành: (2016)
• Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study
  Bằng: Glund, Stephan, et al.
  Được phát hành: (2016)
• Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model
  Bằng: Honickel, M, et al.
  Được phát hành: (2015)